December 26, 2017 / 1:59 PM / 6 months ago

BRIEF-Ligand Pharmaceuticals - Expects Reduction Of Corporate Tax Rate To Reduce Deferred Tax Asset On Balance Sheet By About $40 Mln

* LIGAND PHARMACEUTICALS - EXPECTS REDUCTION OF CORPORATE TAX RATE TO REDUCE DEFERRED TAX ASSET ON BALANCE SHEET BY ABOUT $40 MILLION AS OF SEPT 30, 2017 Source text: (bit.ly/2zy8ap7) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below